PUNE: Serum Institute of India (SII) CEO Adar Poonawalla on Tuesday he described the shipment of Covishield vaccines for the January 16 national inoculation drive as a “proud and historic” moment. Early Tuesday morning, the first shipment of vaccines left the SII facilities in Pune for transport to various parts …
Read More »Explainer: Where are we in the Covid-19 vaccine race?
India became the fourth country to approve a coronavirus vaccine developed by the University of Oxford and AstraZeneca, authorizing the launch of the vaccine in the coming weeks in the country with the second highest number of infections. The following is what we know about the race to deliver vaccines …
Read More »Serum Institute Ready to Sell Oxford Vaccine for Rs 200 to Government, Rs 1000 to Public
Adar Poonawalla, executive director of the Serum Institute, said on Sunday that the Pune-based vaccine manufacturing company obtained authorization from the drug regulator for 50 million doses of the Covishield vaccine, which will be sold at 1,000 rupees to the public and 200 rupees to the public. government. Noting that …
Read More »Live Coronavirus: Vaccine Safety Top Concern, Health Minister Says As Nationwide Trial Begins
Union states and territories across the country are conducting a trial of the coronavirus vaccination process today. It is being carried out in 116 districts at 259 sites, the Health Ministry said on Saturday. The test will be carried out in an integral way of the COVID-19 vaccination process and …
Read More »Panel of Experts Likely to Meet Jan. 1 to Take Final Call on Vaccine Approvals | India News
NEW DELHI: The drug regulator’s Subject Matter Expert Committee (SEC) on the Covid-19 vaccine sought more time to analyze updated data submitted by the Serum Institute of India and Bharat Biotech for emergency use authorization (USA ) for their respective SARS vaccine candidates. CoV2. The committee will meet again on …
Read More »Covid-19: Oxford vaccine may receive approval in a few days | India News
NEW DELHI: India is likely to see the Oxford-AstraZeneca vaccine approved for emergency use in the coming days, as updated data presented by the Serum Institute of India (SII) appears “satisfactory,” top government sources said. Once the data assessment is complete, the regulator may not wait for the vaccine to …
Read More »AstraZeneca Covid-19 Vaccine Has ‘Winning Formula’ – CEO Pascal Soriot
The Covid-19 vaccine developed by British pharmaceutical group AstraZeneca and the University of Oxford has produced a “winning formula” of efficacy, the company’s chief executive said Sunday. The vaccine, which is currently under evaluation by Britain’s independent drug regulator, provides “100 percent protection” against severe Covid disease that requires hospitalization, …
Read More »Oxford / AstraZeneca vaccine should be effective against new variant: Report
LONDON: The Covid-19 vaccine developed by British pharmaceutical group AstraZeneca and the University of Oxford has achieved a “winning formula” of efficacy, the company’s chief executive said on Sunday. In an interview with the Sunday Times newspaper, the company’s chief executive, Pascal Soriot, said the vaccine “should be” effective against …
Read More »Coronavirus vaccine: two doses of the Oxford / AstraZeneca vaccine elicited a good immune response | World News
LONDON: Oxford University’s Covid-19 candidate vaccine has a better immune response when using a two-full-dose regimen rather than a full dose followed by a half-dose booster, the university said Thursday, citing data from the first trials. The developers of the candidate vaccine, which has been licensed to the pharmaceutical company …
Read More »Poor countries face long wait for vaccines despite promises
NEW DELHI: With Americans, British and Canadians rolling up their sleeves for coronavirus vaccines, the route out of the pandemic now seems clear to many in the West, even if implementation will take many months. But for the poorest countries, the road will be much longer and bumpier. The ambitious …
Read More »